Literature DB >> 27516426

DMF: a promising therapeutic option in CTCL.

Ivana Vancurova1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27516426      PMCID： PMC4982450          DOI： 10.1182/blood-2016-06-722462

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  NFκB function and regulation in cutaneous T-cell lymphoma.

Authors:  Tzu-Pei Chang; Ivana Vancurova
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

2.  Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL.

Authors:  Ashish Juvekar; Subrata Manna; Sitharam Ramaswami; Tzu-Pei Chang; Hai-Yen Vu; Chandra C Ghosh; Mahmut Y Celiker; Ivana Vancurova
Journal:  Mol Cancer Res       Date:  2011-01-11       Impact factor: 5.852

3.  Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.

Authors:  Tzu-Pei Chang; Vladimir Poltoratsky; Ivana Vancurova
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

4.  Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis.

Authors:  Aurore Sors; Francette Jean-Louis; Claire Pellet; Liliane Laroche; Louis Dubertret; Gilles Courtois; Hervé Bachelez; Laurence Michel
Journal:  Blood       Date:  2005-10-11       Impact factor: 22.113

5.  How I treat mycosis fungoides and Sézary syndrome.

Authors:  Sean Whittaker; Richard Hoppe; H Miles Prince
Journal:  Blood       Date:  2016-05-05       Impact factor: 22.113

Review 6.  Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.

Authors:  Sarah I Jawed; Patricia L Myskowski; Steven Horwitz; Alison Moskowitz; Christiane Querfeld
Journal:  J Am Acad Dermatol       Date:  2014-02       Impact factor: 11.527

7.  Bcl3 regulates pro-survival and pro-inflammatory gene expression in cutaneous T-cell lymphoma.

Authors:  Tzu-Pei Chang; Ivana Vancurova
Journal:  Biochim Biophys Acta       Date:  2014-07-30

8.  Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.

Authors:  Jan P Nicolay; Karin Müller-Decker; Anne Schroeder; Markus Brechmann; Markus Möbs; Cyrill Géraud; Chalid Assaf; Sergij Goerdt; Peter H Krammer; Karsten Gülow
Journal:  Blood       Date:  2016-06-06       Impact factor: 22.113

9.  Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma.

Authors:  Michael K Kiessling; Claus D Klemke; Marcin M Kaminski; Ioanna E Galani; Peter H Krammer; Karsten Gülow
Journal:  Cancer Res       Date:  2009-03-03       Impact factor: 12.701

Review 10.  Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).

Authors:  Elise Olsen; Eric Vonderheid; Nicola Pimpinelli; Rein Willemze; Youn Kim; Robert Knobler; Herschel Zackheim; Madeleine Duvic; Teresa Estrach; Stanford Lamberg; Gary Wood; Reinhard Dummer; Annamari Ranki; Gunter Burg; Peter Heald; Mark Pittelkow; Maria-Grazia Bernengo; Wolfram Sterry; Liliane Laroche; Franz Trautinger; Sean Whittaker
Journal:  Blood       Date:  2007-05-31       Impact factor: 22.113
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.